Related Experiment Video
Updated: Dec 3, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting
Elizabeth C S Swart1, Natasha Parekh1, Jessica Daw2
1Centers for Value-Based Pharmacy Initiatives and High-Value Health Care, UPMC Health Plan, Pittsburgh, PA.
Journal of Managed Care & Specialty Pharmacy
|October 29, 2020
Summary
Value-based purchasing (VBP) contracts link drug payment to patient outcomes. The Delphi technique can build consensus among stakeholders like patients and providers for more effective VBP agreements.
Area of Science:
- Health economics
- Pharmaceutical policy
- Outcomes research
Background:
- Value-based purchasing (VBP) contracts are increasingly used in the US pharmaceutical market.
- These contracts shift from volume-based to value-based payment models, aiming for high-quality, affordable care.
- Successful VBP requires agreement on measurable outcomes reflecting drug performance.
Purpose of the Study:
- To explore the use of the Delphi technique to inform pharmaceutical value-based contract development.
- To align interests of all key stakeholders, including patients, providers, and payers.
- To enhance transparency and effectiveness of VBP agreements.
Main Methods:
- The Delphi surveying technique was employed to gather stakeholder input.
- Studies were conducted across five distinct disease contexts.
- Consensus was built on key elements for VBP contract development.
Main Results:
- The Delphi technique facilitated stakeholder consensus on critical VBP contract components.
- Insights were gained on practical considerations for real-world VBP implementation.
- The method proved effective in soliciting input from underrepresented stakeholders.
Conclusions:
- The Delphi technique is a valuable tool for developing transparent and effective pharmaceutical VBP contracts.
- It promotes shared learning and aligns diverse stakeholder interests.
- This approach can improve the design and impact of future value-based initiatives.
Related Concept Videos
01:26Drug Discovery: Overview
10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
97
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
97
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
283
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
283
01:11Guidelines for Writing Outcome
3.5K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.5K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
115
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
115
01:20Measurement of Bioavailability: Pharmacodynamic Methods
103
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
103